Below are the most recent publications written about "Vitreoretinopathy, Proliferative" by people in Profiles.
-
Crispin M, Gerhart J, Heffer A, Martin M, Abdalla F, Bravo-Nuevo A, Philp NJ, Kuriyan AE, George-Weinstein M. Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2023 Feb 01; 64(2):1.
-
Mundae R, Haq Z, Adams OE, Parke DW, Tang PH. Evolving Trends for the Clinical Presentation of Primary Rhegmatogenous Retinal Detachments From Early to Late Phases of the COVID-19 Pandemic. Ophthalmic Surg Lasers Imaging Retina. 2023 02; 54(2):78-83.
-
Starr MR, Huang D, Wong JC, Patel LG, Ammar M, Hsu J, Sivalingam A, Mehta S, Ho AC, Kuriyan AE, Khan MA, Cohen MN, Xu D, Lee D, Moster MR, Yonekawa Y. PREVALENCE, CHARACTERISTICS, AND OUTCOMES OF RHEGMATOGENOUS RETINAL DETACHMENT IN EYES WITH TRABECULECTOMY OR GLAUCOMA DRAINAGE DEVICES. Retina. 2022 11 01; 42(11):2039-2045.
-
Wang V, Heffer A, Roztocil E, Feldon SE, Libby RT, Woeller CF, Kuriyan AE. TNF-a and NF-?B signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy. PLoS One. 2022; 17(9):e0271950.
-
Mahmoudzadeh R, Mokhashi N, Anderson H, Patel S, Salabati M, Chiang A, Kuriyan AE, Gupta OP, Mehta S, Garg SJ, Hsu J. Outcomes of Retinectomy without Lensectomy in Rhegmatogenous Retinal Detachments with Proliferative Vitreoretinopathy. Ophthalmol Retina. 2023 01; 7(1):52-58.
-
Israilevich RN, Starr MR, Mahmoudzadeh R, Salabati M, Swaminathan V, Huang D, Kuriyan AE, Yonekawa Y, Garg SJ, Mehta S, Regillo CD, Hsu J. Factors Associated With Good Visual Acuity Outcomes After Retinectomy in Eyes With Proliferative Vitreoretinopathy. Am J Ophthalmol. 2022 08; 240:143-148.
-
Patel SN, Salabati M, Mahmoudzadeh R, Obeid A, Kuriyan AE, Yonekawa Y, Klufas MA, Garg SJ, Hsu J, Khan MA. SURGICAL FAILURES AFTER PRIMARY SCLERAL BUCKLING FOR RHEGMATOGENOUS RETINAL DETACHMENT: Comparison of Eyes With and Without Proliferative Vitreoretinopathy. Retina. 2021 Nov 01; 41(11):2288-2295.
-
Heffer AM, Wang V, Libby RT, Feldon SE, Woeller CF, Kuriyan AE. Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model. PLoS One. 2020; 15(12):e0243626.
-
Heffer A, Wang V, Sridhar J, Feldon SE, Libby RT, Woeller CF, Kuriyan AE. A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells. Transl Vis Sci Technol. 2020 06; 9(7):9.
-
Schwartz SG, Flynn HW, Wang X, Kuriyan AE, Abariga SA, Lee WH. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy. Cochrane Database Syst Rev. 2020 05 13; 5:CD006126.